<?xml version="1.0" encoding="UTF-8" ?>

    <journal>
    <language>en</language>
    <journal_id_issn>2008-2835</journal_id_issn>
    <journal_id_issn_online>2008-4625</journal_id_issn_online>
    <journal_id_pii></journal_id_pii>
    <journal_id_doi></journal_id_doi>
    <journal_id_isnet></journal_id_isnet>
    <journal_id_iranmedex>276</journal_id_iranmedex>
    <journal_id_magiran>5669</journal_id_magiran>
    <journal_id_sid>11181</journal_id_sid>
    <pubdate>
	    <type>gregorian</type>
	    <year>>2022</year>
	    <month>>January-March</month>
	    <day></day>
    </pubdate>
    <volume>14</volume>
    <number>1</number>
    <publish_type>online</publish_type>
    <publish_edition>1</publish_edition>
    <article_type>fulltext</article_type>
    <articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>35509361</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Protection against the Omicron and Subsequent Coronavirus Variants:  Medical-grade Masking, Third Dose Vaccination, Updating Vaccines, and Pursuing  Universal Vaccine</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract></abstract>
	<keyword_fa></keyword_fa>
	<keyword>COVID-19 Pandemic, Mask, Mass active immunization, SARS-CoV-2</keyword>
	<start_page>1</start_page>
	<end_page>2</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=60489</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/60489.pdf</pdf_url>
	<author_list><author><first_name>Ahmad</first_name><middle_name></middle_name><last_name>Shamabadi</last_name><suffix></suffix><affiliation>School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>71806</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Shahin</first_name><middle_name></middle_name><last_name>Akhondzadeh</last_name><suffix></suffix><affiliation></affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>739</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>35509363</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;More than a year has passed since the beginning of the 2019 novel coronavirus diseases (COVID-19) pandemic which has created massive problems globally affecting all aspects of people&amp;#39;s life. Due to the emergence of new strains of the SARS-CoV-2, pandemic risk still remains, despite the start of vaccination. Therefore, rapid diagnostic tests are essential to control infection, improve clinical care and stop the spread of the disease. Recently CRISPR-based diagnostic tools have facilitated rapid diagnostic. Here, we review the diagnostic applications of CRISPR-Cas system in COVID-19.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>COVID-19, CRISPR-Cas systems, SARS-CoV-2</keyword>
	<start_page>3</start_page>
	<end_page>9</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=40489</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/40489.pdf</pdf_url>
	<author_list><author><first_name>Hashem</first_name><middle_name></middle_name><last_name>Khanbabaei</last_name><suffix></suffix><affiliation>Department of Radiologic Sciences and Medical Physics, Faculty of Allied Medicine, Kerman University of Medical Sciences, Kerman, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>71814</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Samaneh</first_name><middle_name></middle_name><last_name>Abbasi</last_name><suffix></suffix><affiliation>Abadan University of Medical Sciences, Abadan, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>71815</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mona</first_name><middle_name></middle_name><last_name>Fani</last_name><suffix></suffix><affiliation>Department of Pathobiology and Laboratory Sciences, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Bojnurd, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>71816</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Saber</first_name><middle_name></middle_name><last_name>Soltani</last_name><suffix></suffix><affiliation>Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>71817</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Milad</first_name><middle_name></middle_name><last_name>Zandi</last_name><suffix></suffix><affiliation>Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>71818</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Zahra</first_name><middle_name></middle_name><last_name>Najafimemar</last_name><suffix></suffix><affiliation>Infectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81817</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Saeedeh</first_name><middle_name></middle_name><last_name>Ebrahimi</last_name><suffix></suffix><affiliation></affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>71813</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>35509365</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Non-gynaecological Applications of Menstrual-derived Stem Cells: A Systematic  Review</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Menstrual-derived Stem Cells (MenSC) are a potential novel source of mesenchymal stem cells. There is an increased interest in investigating the therapeutic potential of MenSC due to the various advantages they exhibit&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;, when &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;compared to other types of stem cells. MenSC are obtained &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;non-invasively &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;from menstrual blood. Thus, collection of MenSC is simple, reproducible and can be &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;carried out&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; periodically&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;, &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;with &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;minimal &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;complications. MenSC are present in abundance, are highly proliferative, exhibit a low immunogenicity&lt;/span&gt; &lt;span style=&quot;font-size:10.0pt&quot;&gt;and lack ethical issues. MenSC have shown the ability to differentiate into several lineages. &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;The&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; therapeutic potential of MenSC in non-gynaecological applications ha&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;s&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; been investigated in wound healing, neurological, musculo-skeletal,&amp;nbsp; cardiovascular, respiratory&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;, and &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;liver disorders, &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;as well as in &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;diabetes and cancer. Human clinical trials are limited&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;. T&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;o date, therapeutic efficacy and safety have been reported in patients with Avian influenza A subtype H7N9, &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;COVID-19&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;, congestive heart failure, multiple sclerosis and Duchene muscular dystrophy. However, further clinical trials in humans should be conducted, to study the long-term therapeutic effects of these stem cells in various diseases and to further explore their mechanism of action. This systematic review focuses on the application of MenSC in non-gynaecological diseases.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Cell therapy, Menstruation, Mesenchymal stem cells, Regenerative medicine, Stem cells</keyword>
	<start_page>10</start_page>
	<end_page>29</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=40490</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/40490.pdf</pdf_url>
	<author_list><author><first_name>Claire</first_name><middle_name></middle_name><last_name>Galea</last_name><suffix></suffix><affiliation></affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>71819</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Nicoletta</first_name><middle_name></middle_name><last_name>Riva</last_name><suffix></suffix><affiliation>Department of Pathology, Faculty of Medicine and Surgery, University of Malta, Msida, Malta</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>71820</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Jean</first_name><middle_name></middle_name><last_name>Calleja-Agius</last_name><suffix></suffix><affiliation>Department of Anatomy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>71821</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>35509358</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>New Generation Vaccines for COVID-19 Based on Peptide, Viral Vector, Artificial  Antigen Presenting Cell, DNA or mRNA</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;At present, effective vaccines have been developed as the most successful approaches for preventing widespread infectious disease. The global efforts are focusing with the aim of eliminating and overcoming the &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Coronavirus Disease 2019 (COVID-19)&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; and are developing vaccines from the date it was announced as a pandemic disease. In this study, PubMed, Embase, Cochrane Library, Clinicaltrial.gov, WHO reports, Science Direct, Scopus, Google Scholar, and Springer databases were searched for finding the relevant studies&lt;/span&gt; &lt;span style=&quot;font-size:10.0pt&quot;&gt;about the COVID-19 vaccines. This article provides an overview of multiple vaccines that have been manufactured from December 2020 up to April 2021 and also offers a perspective on their efficacy, safety, advantages, and limitations. Currently, there are several categories of COVID-19 vaccines based on Protein Subunit (PS), Inactivated Virus (IV), Virus Like Particle (VLP), Live Attenuated Virus (LAV), Viral Vector (replicating) (VVr) and Viral Vector (non-replicating) (VVnr) in progress or finalized as indicated by the WHO reporting of April 1, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>COVID-19, Pandemics, SARS-CoV-2, Vaccines</keyword>
	<start_page>30</start_page>
	<end_page>36</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=40491</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/40491.pdf</pdf_url>
	<author_list><author><first_name>Marzieh</first_name><middle_name></middle_name><last_name>Rezaei</last_name><suffix></suffix><affiliation>Department of Cell & Molecular Biology and Microbiology, Faculty of Science and Biotechnology, University of Isfahan, Isfahan, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>71822</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mahboobeh</first_name><middle_name></middle_name><last_name>Nazari</last_name><suffix></suffix><affiliation></affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>11474</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>35509360</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Monoclonal Antibody Against Sortilin Induces Apoptosis in Human Breast Cancer Cells</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Background:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Sortilin has an important role in various malignances and can be used as a promising target to eradicate cancer cells.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Methods:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; In this study, the expression of sortilin in 4T1 and MDA-MB231 cell lines was evaluated by flow cytometry and immunocytochemistry. Apoptosis assay was also applied to evaluate apoptosis induction in 4T1 and MDA-MB231 cell lines. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Results:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Based on cell surface flow cytometry results, anti-sortilin (2D8-E3) mAb could recognize sortilin molecules in 79.2% and 90.3% of 4T1 and MDA-MB231 cell-lines, respectively. The immunocytochemistry staining results confirmed sortilin surface expression. Apoptosis assay indicated that anti-sortilin mAb could induce apoptosis in 4T1 and MDA-MB231 cell lines.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Our study revealed the important role of surface sortilin in breast carcinoma cell survival and its possible application as a therapeutic agent in cancer targeted therapies.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Breast cancer, Flow cytometry, Monoclonal antibody, Sortilin</keyword>
	<start_page>37</start_page>
	<end_page>45</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=40492</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/40492.pdf</pdf_url>
	<author_list><author><first_name>Miganoosh</first_name><middle_name></middle_name><last_name>Simonian</last_name><suffix></suffix><affiliation>Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>71823</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mozhan</first_name><middle_name></middle_name><last_name>Haji Ghaffari</last_name><suffix></suffix><affiliation>Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>71824</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Ali</first_name><middle_name></middle_name><last_name>Salimi</last_name><suffix></suffix><affiliation>Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>352</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Ebrahim</first_name><middle_name></middle_name><last_name>Mirzadegan</last_name><suffix></suffix><affiliation>Nanobiotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>653</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Niloufar</first_name><middle_name></middle_name><last_name>Sadeghi</last_name><suffix></suffix><affiliation>Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>41592</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Nasim</first_name><middle_name></middle_name><last_name>Ebrahimnezhad</last_name><suffix></suffix><affiliation>Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>71827</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Ghazaleh</first_name><middle_name></middle_name><last_name>Fazli</last_name><suffix></suffix><affiliation>Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>71828</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Ramina</first_name><middle_name></middle_name><last_name>Fatemi</last_name><suffix></suffix><affiliation>Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>71829</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Ali Ahmad</first_name><middle_name></middle_name><last_name>Bayat </last_name><suffix></suffix><affiliation>Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>835</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Saeideh</first_name><middle_name></middle_name><last_name>Milani</last_name><suffix></suffix><affiliation>Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>21487</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Babak</first_name><middle_name></middle_name><last_name>Negahdari</last_name><suffix></suffix><affiliation></affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>71831</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Hodjattallah</first_name><middle_name></middle_name><last_name>Rabbani</last_name><suffix></suffix><affiliation></affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>24</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>35509364</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Exogenous Production of N-acetylmuramyl-L Alanine Amidase (LysM2) from  Siphoviridae Phage Affecting Anti-Gram-Negative Bacteria: Evaluation of Its Structure and Function</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Background:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; To obtain endolysin with impact(s) on gram-negative bacteria as well as gram-positive bacteria, N-acetylmuramyl L-alanine-amidase&lt;em&gt; &lt;/em&gt;(MurNAc-LAA) from a &lt;em&gt;Bacillus subtilis&lt;/em&gt;-hosted Siphoviridae phage (SPP1 phage, Subtilis Phage Pavia 1) was exogenously expressed in &lt;em&gt;Escherichia coli (&lt;/em&gt;&lt;em&gt;E. coli).&lt;/em&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Methods:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The sequences of &lt;em&gt;MurNAc-LAA&lt;/em&gt; genes encoding peptidoglycan hydrolases were obtained from the Virus-Host database. The sequence of&lt;em&gt; &lt;/em&gt;MurNAc-LAA&lt;em&gt; &lt;/em&gt;was optimized by GenScript software to generate&lt;em&gt; &lt;/em&gt;MurNAc-LAA-MMI (LysM2) for optimal expression in &lt;em&gt;E. coli&lt;/em&gt;. Furthermore, the structure and function of&lt;em&gt; &lt;/em&gt;LysM2 was evaluated &lt;em&gt;in silico.&lt;/em&gt; The optimized gene was synthesized, subcloned in the pET28a, and expressed in &lt;em&gt;E. coli&lt;/em&gt; BL21(DE3). The antibacterial effects of the protein on the peptidoglycan substrates were studied. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Results:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; &lt;em&gt;LysM2&lt;/em&gt;, on 816 &lt;em&gt;bp&lt;/em&gt; gene encoding a 33 &lt;em&gt;kDa&lt;/em&gt; protein was confirmed as specific SPP1 phage enzyme. The enzyme is composed of 271 amino acids, with a half-life of 10 &lt;em&gt;hr&lt;/em&gt; in &lt;em&gt;E.&lt;/em&gt;&lt;/span&gt;&lt;em&gt; &lt;/em&gt;&lt;em&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;coli&lt;/span&gt;&lt;/em&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;. &lt;em&gt;In silico&lt;/em&gt; analyses showed 34.2% alpha-helix in the secondary structure, hydrophobic N-terminal, and lysine-rich C-terminal, and no antigenic properties in LysM2 protein. This optimized endolysin revealed impacts against &lt;em&gt;Proteus &lt;/em&gt;(sp) by turbidity, and an antibacterial activity against &lt;em&gt;Klebsiella pneumoniae&lt;/em&gt;, &lt;em&gt;Salmonella typhimurium&lt;/em&gt;, and &lt;em&gt;Proteus vulgaris&lt;/em&gt; in agar diffusion assays. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Taken together, our results confirmed that LysM2 &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;is an inhibiting agent for gram-negative bacteria.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Antibacterial activity, Bacteriophage SPP1, Endolysin, Siphoviridae</keyword>
	<start_page>46</start_page>
	<end_page>53</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=50488</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/50488.pdf</pdf_url>
	<author_list><author><first_name>Morteza</first_name><middle_name></middle_name><last_name>Miri</last_name><suffix></suffix><affiliation>Department of Biotechnology, Faculty of Biotechnology, Semnan University, Semnan, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81813</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Sepideh</first_name><middle_name></middle_name><last_name>Yazdianpour</last_name><suffix></suffix><affiliation>Department of Biotechnology, Faculty of Biotechnology, Semnan University, Semnan, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81816</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Shamsozoha</first_name><middle_name></middle_name><last_name>Abolmaali</last_name><suffix></suffix><affiliation></affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81814</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Shakiba</first_name><middle_name></middle_name><last_name>Darvish Alipour Astaneh </last_name><suffix></suffix><affiliation>Department of Biotechnology, Faculty of Biotechnology, Semnan University, Semnan, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>41622</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>35509366</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Genome Analysis of the Enterococcus faecium Entfac.YE Prophage</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Background:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Bacteriophages are viruses that infect bacteria. Bacteriophages are widely distributed in various environments. The prevalence of bacteriophages in water sources, especially wastewaters, is naturally high. These viruses affect evolution of most bacterial species. Bacteriophages are able to integrate their genomes into the chromosomes of their hosts as prophages and hence transfer resistance genes to the bacterial genomes. Enterococci are commensal bacteria that show high resistance to common antibiotics. For example, prevalence of vancomycin-resistant enterococci has increased within the last decades. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Methods:&lt;/span&gt;&lt;strong&gt; &lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Enterococcal isolates were isolated from clinical samples and morphological, phenotypical, biochemical, and molecular methods were used to identify and confirm their identity. Bacteriophages extracted from water sources were then applied to isolated &lt;em&gt;Enterococcus faecium (E. faecium)&lt;/em&gt;. In the next step, the bacterial genome was completely sequenced and the existing prophage genome in the bacterial genome was analyzed.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Results:&lt;/span&gt; &lt;span style=&quot;font-size:10.0pt&quot;&gt;In this study,&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; &lt;em&gt;E. faecium&lt;/em&gt; &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;EntfacYE was isolated from a clinical sample. The EntfacYE genome was analyzed and 88 prophage genes were identified. The prophage content included four housekeeping genes, 29 genes in the group of genes related to replication and regulation, 25 genes in the group of genes related to &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;structure and packaging, and four genes belonging to the group of genes associated with lysis. Moreover, 26 genes were identified with unknown functions. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;strong&gt; &lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;In conclusion, genome analysis of prophages can lead to a better understanding of their roles in the rapid evolution of bacteria.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Antibacterial agents, Bacteriophages, Enterococcus faecium, Genome analysis, Prophages</keyword>
	<start_page>54</start_page>
	<end_page>60</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=50489</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/50489.pdf</pdf_url>
	<author_list><author><first_name>Yara</first_name><middle_name></middle_name><last_name>Elahi</last_name><suffix></suffix><affiliation>Department of Genetics, Faculty of Life Sciences, Islamic Azad University Tehran North Branch, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81818</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Ramin</first_name><middle_name></middle_name><last_name>Mazaheri Nezhad Fard</last_name><suffix></suffix><affiliation>Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81819</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Arash</first_name><middle_name></middle_name><last_name>Seifi</last_name><suffix></suffix><affiliation>Department of Infectious Diseases, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81820</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Saeideh</first_name><middle_name></middle_name><last_name>Mahfouzi</last_name><suffix></suffix><affiliation>Department of Virology, School of Public Health, Tehran University of Medical Sciences,, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81821</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Ali Akbar</first_name><middle_name></middle_name><last_name>Saboor Yaraghi</last_name><suffix></suffix><affiliation></affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81822</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>35509359</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Optimization of Expression and Purification of Recombinant Mouse plac1</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Background:&lt;/span&gt;&lt;strong&gt; &lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Placenta-specific 1 (&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;PLAC1) is one of the recently-discovered Cancer-Testis-Placenta (CTP) antigen with restricted normal tissue and ectopic expression &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;in a wide range of cancer cells from &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;different histological origins. The production of recombinant human PLAC1 has already been optimized; however, no study has been reported so far on the production and purification of mouse plac1. &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;In this study, mouse &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;plac1 &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;expression and purification was optimized in a prokaryotic system and the effects of the generated proteins on inducing humoral responses in mice were investigated. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Methods:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; A fusion protein containing full extracellular domain of mouse&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; plac1&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;, immunostimulatory peptides, tetanus toxin P2P30 and PADRE and KDEL3 signal (main &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;plac1&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;), and the same fragment without immunostimulatory peptides (control &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;plac1&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;) was produced. To optimize production and purification steps, different parameters including bacterial strain, cultivation temperature, cultivation time, &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;IPTG&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; concentration&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;, culture medium, and also different buffers for purification of the recombinant proteins were tested. &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;After confirming the identity of recombinant &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;plac1 &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;proteins with Western Blotting (WB) and ELISA assays, these proteins were &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;subcutaneously&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; injected in mice with Freund&amp;#39;s adjuvant and the anti-&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;plac1&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; antibody response was detected by ELISA. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Results:&lt;/span&gt; &lt;span style=&quot;font-size:10.0pt&quot;&gt;The optimal expression level of &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;main and control &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;plac1 &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;was&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; obtained in BL21 (DE3) and TB culture medium in the presence of 0.25 &lt;em&gt;mM&lt;/em&gt; IPTG after 24 &lt;em&gt;hr&lt;/em&gt; of induction at 15&lt;/span&gt;&lt;em&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&amp;deg;&lt;/span&gt;&lt;/em&gt;&lt;em&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;C&lt;/span&gt;&lt;/em&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;. The buffer containing 2% sarkosyl produced higher yield and purity. Our results showed specific reactivity of anti-human recombinant plac1 polyclonal antibody with both main and control plac1 recombinant proteins in WB and ELISA analysis. Both proteins induced humoral responses in mice; however, anti-plac1 &amp;nbsp;antibody titer was significantly higher in sera of mice immunized with main compared to control plac1. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Conclusion:&lt;/span&gt; &lt;span style=&quot;font-size:10.0pt&quot;&gt;In this study, an optimized protocol for production and purification of mouse &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;plac1 &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;was reported and it was shown that insertion of immunostimulatory peptides in gene construct could efficiently enhance humoral immune responses against mouse&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; plac1&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;, which could potentially augment cellular immune responses against &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;plac1 &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;leading to more effective anti-cancer responses.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Expression, Mouse plac1, Optimization, Purification, Recombinant proteins</keyword>
	<start_page>61</start_page>
	<end_page>69</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=50490</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/50490.pdf</pdf_url>
	<author_list><author><first_name>Shaghayegh</first_name><middle_name></middle_name><last_name>Rahdan</last_name><suffix></suffix><affiliation>Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81825</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mahboobeh</first_name><middle_name></middle_name><last_name>Nazari</last_name><suffix></suffix><affiliation>Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>11474</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Sorour</first_name><middle_name></middle_name><last_name>Shojaeian</last_name><suffix></suffix><affiliation>Department of Biochemistry, School of Medical Sciences, Alborz University of Medical Sciences, Karaj, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>61712</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Fazel</first_name><middle_name></middle_name><last_name>Shokri</last_name><suffix></suffix><affiliation>Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>5</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mohammad Mehdi</first_name><middle_name></middle_name><last_name>Amiri</last_name><suffix></suffix><affiliation>Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>21542</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Amin</first_name><middle_name></middle_name><last_name>Ramezani</last_name><suffix></suffix><affiliation>Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>987</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Amir-Hassan</first_name><middle_name></middle_name><last_name>Zarnani</last_name><suffix></suffix><affiliation></affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>7</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Seyed Alireza</first_name><middle_name></middle_name><last_name>Razavi</last_name><suffix></suffix><affiliation>Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81823</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed> 35509362</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Background:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Lipopeptides are potential microbial metabolites that are abandoned with broad spectrum biopharmaceutical properties ranging from antimicrobial, antiviral and anticancer, &lt;em&gt;etc&lt;/em&gt;. Clinical studies are not much explored beyond the experimental methods to understand drug mechanisms on target proteins at the molecular level for large molecules. Due to the less available studies on potential target proteins of lipopeptide based drugs, their potential inhibitory role for more obvious treatment on disease have not been explored in the direction of lead optimization. However, Computational approaches need to be utilized to explore drug discovery aspects on lipopeptide based drugs, which are time saving and cost-effective techniques. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Methods:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Here a ligand-based drug discovery approach is coupled with reverse pharmacophore-mapping for the prediction of potential targets for antiviral (&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;SARS-nCoV-2&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;) and anticancer lipopeptides.&amp;nbsp;Web-based servers PharmMapper and SwissTargetPrediction are used for the identification of target proteins for lipopeptides surfactin and iturin produced by&amp;nbsp;&lt;em&gt;Bacillus subtilis&lt;/em&gt;. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Results:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The studies have given the insight to treat the diseases with next-generation large molecule therapeutics. Results also indicate the affinity for Angiotensin-Converting Enzymes (ACE) and proteases as the potential viral targets for these categories of peptide therapeutics. A target protein for the Human Papilloma Virus (HPV) has also been mapped. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The work will further help in exploring computer-aided drug designing of novel compounds with greater efficiency where the structure of the target proteins and lead compounds are known.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Antiviral Agents, Bacillus subtillis, Drug discovery, Ligands, Lipopeptides, Peptide hydrolases</keyword>
	<start_page>70</start_page>
	<end_page>78</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=50492</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/50492.pdf</pdf_url>
	<author_list><author><first_name>Manisha</first_name><middle_name></middle_name><last_name>Yadav</last_name><suffix></suffix><affiliation>Department of Biotechnology, National Institute of Technology Raipur, Chhattisgarh, India</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81826</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>J. Satya</first_name><middle_name></middle_name><last_name>Eswari</last_name><suffix></suffix><affiliation></affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81827</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>35509356</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Fluorescent Detection of Methicillin Resistant Staphylococcus aureus by  Loop-mediated Isothermal Amplification Assisted with Streptavidin-coated Quantum Dots</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;Background:&lt;span style=&quot;font-size:11.5pt&quot;&gt; Methicillin Resistance&lt;em&gt; Staphylococcus aureus&lt;/em&gt; (&lt;em&gt;MRSA&lt;/em&gt;) could be considered as a major concern in medicine can cause nosocomial infection and bacteremia, especially in patients using catheter and household medical devices. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;Methods: &lt;span style=&quot;font-size:11.5pt&quot;&gt;Using molecular diagnostic methods are important for identification of&lt;em&gt; MRSA &lt;/em&gt;from the Methicillin Sensitive&lt;em&gt; Staphylococcus aureus&lt;/em&gt; (&lt;em&gt;MSSA&lt;/em&gt;). Here we described a fluorescent assay using biotin-labelling Loop-mediated isothermal amplification (LAMP) method assisted with streptavidin-coated Quantum Dots (QDs) for detection of &lt;em&gt;MRSA&lt;/em&gt;. For comparison, another fluorescent assay using LAMP assisted with Green Viewer (GV; a fluorescent dye) was applied for detection of &lt;em&gt;MRSA&lt;/em&gt;. The &lt;em&gt;mecA&lt;/em&gt; gene was selected as the target for amplification by LAMP and for biotin-labeling of the LAMP amplicons, biotin-11-dUTP was mixed with the dNTPs (deoxy Nucleotide Phosphates) in LAMP reaction. For determining the clinical performance of the developed assay, 30 blood samples with &lt;em&gt;MRSA&lt;/em&gt; positive results were tested with QD-LAMP&lt;/span&gt;&lt;span style=&quot;font-size:11.5pt&quot;&gt;, the conventional LAMP, GV-LAMP, and &lt;/span&gt;&lt;span style=&quot;font-size:11.5pt&quot;&gt;Polymerase Chain Reaction&lt;/span&gt;&lt;span style=&quot;font-size:11.5pt&quot;&gt; (PCR). &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;Results: &lt;span style=&quot;font-size:11.5pt&quot;&gt;Obtained results indicated that % sensitivity of QD-LAMP was 86.66% for detection of &lt;em&gt;mecA&lt;/em&gt; positive &lt;em&gt;MRSA&lt;/em&gt; samples; however, the Limit of Detection (LoD) of QD-LAMP was &lt;/span&gt;&lt;span style=&quot;font-size:11.5pt&quot;&gt;1.5&amp;times;10&lt;sup&gt;4&lt;/sup&gt;&lt;/span&gt; &lt;span style=&quot;font-size:11.5pt&quot;&gt;Colony Forming Unit&lt;/span&gt;&lt;span style=&quot;font-size:11.5pt&quot;&gt; (CFU). &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;Conclusion: &lt;span style=&quot;font-size:11.5pt&quot;&gt;The results suggested that &lt;/span&gt;&lt;span style=&quot;font-size:11.5pt&quot;&gt;the QD-LAMP &lt;/span&gt;&lt;span style=&quot;font-size:11.5pt&quot;&gt;assay was easy to operate and could be used for detection of &lt;em&gt;MRSA&lt;/em&gt; in parallel to the blood culture with less sensitivity for detection of bacteremia and pediatric septicemia with low counts of &lt;em&gt;MRSA&lt;/em&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>LAMP, MRSA, MSSA, Quantum dots, mecA gene</keyword>
	<start_page>79</start_page>
	<end_page>88</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=60491</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/60491.pdf</pdf_url>
	<author_list><author><first_name>Aily</first_name><middle_name></middle_name><last_name>Aliasgharian</last_name><suffix></suffix><affiliation>Department of Medical Microbiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>91821</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Pooria</first_name><middle_name></middle_name><last_name>Gill</last_name><suffix></suffix><affiliation></affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>31592</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mohammad</first_name><middle_name></middle_name><last_name>Ahanjan</last_name><suffix></suffix><affiliation>Research Center for Pediatric Infectious Diseases, Mazandaran University of Medical Sciences, Sari, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>91823</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Adele</first_name><middle_name></middle_name><last_name>Rafati</last_name><suffix></suffix><affiliation>Immunogenetics Research Center, Department of Medical Nanotechnology, Faculty of Advanced     Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>91824</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed></article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Antitumor Activities of Green Tea by Up-regulation of miR -181a Expression in LNCaP Cells Using 3D Cell Culture Model</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Background:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Prostate Cancer (PCa) is the major reason for the high mortality rates among men worldwide. In fact, current therapeutic approaches are not successful. It appears that discovering more effective methods considering several parameters such as availability, low cost, and no toxicity to normal cells is one of the biggest challenges for interested researchers. Green tea (extracted from the plant &lt;em&gt;Camellia sinensis&lt;/em&gt;) with high level of polyphenolic compounds and as the most globally consumed beverage has attracted considerable interest. MicroRNAs (or miRNAs) were considered as novel tools in cancer therapy which modulate various biological events in cell by regulation of gene expression. The aim of the current study was to evaluate the antitumor activity of green tea in LNCaP cells through up-regulation of miR-181a expression.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Methods:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; First, &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;LNCaP cells were cultured and by using quantitative real time PCR (qRT-PCR) and western blot methods, the expression levels of Bax and BCL2 were analyzed. Next, a 3D cell culture model was applied to evaluate the expression of miRNA-181a &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;in &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;LNCaP cells. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Results:&lt;/span&gt; &lt;span style=&quot;font-size:10.0pt&quot;&gt;It was shown that green tea induced cellular apoptosis. The high number of apoptotic nuclei was also shown by using DAPI staining. The inhibition of tumor growth was revealed by analyzing the size and number of spheroids. Also, up-regulation of miR-181a expression &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;in &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;LNCaP cells was revealed after treatment with green tea. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Conclusion: &lt;/span&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Our results are helpful to design antitumor regimens based on consumption of green&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; tea through up-regulation of miRNA-181a expression and induction of apoptosis.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Apoptosis, Cell culture techniques, Green tea, Proto-oncogene proteins c-bcl-2, Up-regulation</keyword>
	<start_page>89</start_page>
	<end_page>94</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=50494</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/50494.pdf</pdf_url>
	<author_list><author><first_name>Fatemeh</first_name><middle_name></middle_name><last_name>Safari</last_name><suffix></suffix><affiliation></affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81828</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Narjes</first_name><middle_name></middle_name><last_name>Rayat Azad</last_name><suffix></suffix><affiliation>Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81829</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Ali</first_name><middle_name></middle_name><last_name>Alizadeh Ezdiny </last_name><suffix></suffix><affiliation>Department of Biology, Faculty of Basic Sciences, Rasht Branch, Islamic Azad University, Rasht, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81830</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Safoora</first_name><middle_name></middle_name><last_name>Pakizehkar</last_name><suffix></suffix><affiliation>Cellular and Molecular Endocrine Research Center (CMERC), Research Institute for Endocrine Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81831</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Zeinab</first_name><middle_name></middle_name><last_name>Khazaei Koohpar</last_name><suffix></suffix><affiliation>Department of Cell and Molecular Biology, Faculty of Biological Sciences, Tonekabon Branch, Islamic Azad University, Tonekabon, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81832</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Najmeh</first_name><middle_name></middle_name><last_name>Ranji</last_name><suffix></suffix><affiliation>Department of Biology, Faculty of Basic Sciences, Rasht Branch, Islamic Azad University, Rasht, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81833</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>35509357</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Pulse Voltage Electrical Stimulation for Bacterial Inactivation and Wound Healing  in Mice with Diabetes</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Background:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Treatment of wounds in diabetes often gets less than perfect healing. One of the reasons for the difficulty in treating wounds in diabetes is the growth of aerobic and anaerobic bacteria. This study aims to determine the pulse voltage and treatment time that can optimally inactivate bacteria, and their effect on wound healing in mice suffering from diabetes.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Methods:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The study used electrical stimulation with a direct voltage of 10 &lt;em&gt;volts&lt;/em&gt; given a pulse voltage of 50-80 &lt;em&gt;volts&lt;/em&gt;, a width of 50 &lt;em&gt;&amp;micro;s&lt;/em&gt;, and the number of pulses of 65 per second. The research samples were &lt;em&gt;Staphylococcus aureus&lt;/em&gt; (&lt;em&gt;S. aureus&lt;/em&gt;) and &lt;em&gt;Pseudomonas aeruginosa&lt;/em&gt; (&lt;em&gt;P. aeruginosa&lt;/em&gt;) bacteria that grew on beef and mice (&lt;em&gt;Mus musculus&lt;/em&gt;) with diabetes. The treatment for &lt;em&gt;S. aureus&lt;/em&gt; and &lt;em&gt;P. aeruginosa&lt;/em&gt; bacteria was carried out using a pulse voltage of 50-80 &lt;em&gt;volts&lt;/em&gt; for 5-15 &lt;em&gt;min/day&lt;/em&gt; and repeated for 3 days. Meanwhile, treatment of mice wounds was carried out with a pulse voltage of 80 &lt;em&gt;volts&lt;/em&gt; for 15 &lt;em&gt;min/day&lt;/em&gt; and repeated for 7 days.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Results:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The results showed that treatment with a pulse voltage of 50-80 &lt;em&gt;volts&lt;/em&gt; and a treatment time of 5-15 &lt;em&gt;min&lt;/em&gt; significantly reduced the number of &lt;em&gt;S. aureus&lt;/em&gt; and &lt;em&gt;P. aeruginosa&lt;/em&gt; bacteria in beef (p&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&amp;pound;&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;0.05). Treatment with a pulse voltage of 80 &lt;em&gt;volts&lt;/em&gt; for 15 &lt;em&gt;min&lt;/em&gt; made beef free from bacteria. Meanwhile, treatment with a pulse voltage of 80 &lt;em&gt;volts&lt;/em&gt; for 15 &lt;em&gt;min&lt;/em&gt; per day for seven days resulted in the wound state of three mice in the maturation phase and two mice in the proliferation phase on day 8 with an average wound area of 0.108 &lt;em&gt;cm &lt;sup&gt;2&lt;/sup&gt;&lt;/em&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The treatment with a pulse voltage of 80 &lt;em&gt;volts&lt;/em&gt; for 15 &lt;em&gt;min&lt;/em&gt; made the beef sterile, the mice wounds healed quickly, and the mice not stressed. The higher the blood glucose level, the slower the wound healing process.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Bacteria, Electrical stimulation, Pulse voltage, Wound</keyword>
	<start_page>95</start_page>
	<end_page>101</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=50495</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/50495.pdf</pdf_url>
	<author_list><author><first_name>Mokhamad</first_name><middle_name></middle_name><last_name>Tirono</last_name><suffix></suffix><affiliation></affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81834</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Farid</first_name><middle_name></middle_name><last_name>Samsu Hananto</last_name><suffix></suffix><affiliation>Department of Physics, Faculty of Science and Technology, Universitas Islam Negeri Maulana Malik Ibrahim, Malang, Indonesia</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81835</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Ahmad</first_name><middle_name></middle_name><last_name>Abtokhi</last_name><suffix></suffix><affiliation>Department of Physics, Faculty of Science and Technology, Universitas Islam Negeri Maulana Malik Ibrahim, Malang, Indonesia</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>81836</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

